DSpace at RU >

Browsing by Author Easton, D.F.

Full Text	Issue Date	Title	Author(s)
	2012	Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.	Kirchhoff, T.; Gaudet, M.M.; Antoniou, A.C.; McGuffog, L.; Humphreys, M.K., et al
	2012	Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.	Jakubowska, A.; Rozkrut, D.; Antoniou, A.; Hamann, U.; Scott, R.J., et al
	2012	Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)	Pijpe, A.; Andrieu, N.; Easton, D.F.; Kesminiene, A.; Cardis, E., et al
	2012	Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).	Mavaddat, N.; Barrowdale, D.; Andrulis, I.L.; Domchek, S.M.; Eccles, D., et al
	2012	Gene-gene interactions in breast cancer susceptibility.	Turnbull, C.; Seal, S.; Renwick, A.; Warren-Perry, M.; Hughes, D., et al
	2012	A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers.	Ding, Y.C.; McGuffog, L.; Healey, S.; Friedman, E.; Laitman, Y., et al
	2011	Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2	Osorio, A.; Milne, R.L.; Alonso, R.; Pita, G.; Peterlongo, P., et al
	2011	Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers	Beesley, J.; Pickett, H.A.; Johnatty, S.E.; Dunning, A.M.; Chen, X., et al
	2011	Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers	Spurdle, A.B.; Marquart, L.; McGuffog, L.; Healey, S.; Sinilnikova, O., et al
	2011	Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer	Maxwell, C.A.; Benitez, J.; Gomez-Baldo, L.; Osorio, A.; Bonifaci, N., et al
	2011	Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.	Mitra, A.V.; Bancroft, E.K.; Barbachano, Y.; Page, E.C.; Foster, C.S., et al
	2011	Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.	Cox, D.G.; Simard, J.; Sinnett, D.; Hamdi, Y.; Soucy, P., et al
	2011	Exploring the link between MORF4L1 and risk of breast cancer.	Martrat, G.; Maxwell, C.M.; Tominaga, E.; Porta-de-la-Riva, M.; Bonifaci, N., et al
	2011	Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours	Reiman, A.; Srinivasan, V.; Barone, G.; Last, J.I.; Wootton, L.L., et al
	2011	Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3	Purdue, M.P.; Johansson, M.; Zelenika, D.; Toro, J.R.; Scelo, G., et al
	2010	Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.	Engel, C.; Versmold, B.; Wappenschmidt, B.; Simard, J.; Easton, D.F., et al
	2010	Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.	Wang, X.; Pankratz, V.S.; Fredericksen, Z.; Tarrell, R.; Karaus, M., et al
	2010	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Goode, E.L.; Chenevix-Trench, G.; Song, H.; Ramus, S.J.; Notaridou, M., et al
	2009	Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).	Osorio, A.; Milne, R.L.; Pita, G.; Peterlongo, P.; Heikkinen, T., et al
	2009	No evidence that GATA3 rs570613 SNP modifies breast cancer risk.	Johnatty, S.E.; Couch, F.J.; Fredericksen, Z.; Tarrell, R.; Spurdle, A.B., et al
	2009	A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.	Tarpey, P.S.; Smith, R.; Pleasance, E.; Whibley, A.; Edkins, S., et al
	2008	Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.	Antoniou, A.C.; Spurdle, A.B.; Sinilnikova, O.M.; Healey, S.; Pooley, K.A., et al
	2008	Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.	Goldgar, D.E.; Easton, D.F.; Byrnes, G.B.; Spurdle, A.B.; Iversen, E.S., et al
	2007	Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.	Chang-Claude, J.; Andrieu, N.; Rookus, M.A.; Brohet, R.M.; Antoniou, A.C., et al
	1996	Localization of the gene for Cowden disease to chromosome 10q22-23	Nelen, M.R.; Padberg, G.W.; Peeters, E.A.J.; Lin, A.Y.; Helm, B. van den, et al